Documentation
Getting StartedOverview

Overview

What Compass AI does and how it helps you understand your IAM infrastructure.

Compass AI is an identity and access management (IAM) discovery and assessment platform. It connects to your existing IAM systems, pulls real operational data, and uses AI to generate structured reports with actionable recommendations.

How It Works

Compass follows a simple three-step flow:

  1. Connect — Link your IAM systems (Azure AD, Okta, SailPoint, CyberArk, etc.) so Compass can pull live metrics
  2. Discover — The AI analyses your connector data and generates a comprehensive report covering governance maturity, access risks, operational efficiency, and more
  3. Act — Review findings, use Calibration to finalize the first report into a trusted baseline, dig deeper into specific areas, and track improvements over time with reruns

What You Get

Every discovery generates a structured report that includes:

  • Executive Summary — High-level assessment of your IAM posture with an overall maturity score
  • Key Metrics — Quantified measurements like orphan account rates, access certification completion, provisioning times, and privilege escalation risks
  • Key Findings — Prioritised issues ranked by severity and business impact
  • Action Plan — Concrete recommendations with estimated effort and expected outcomes
  • Benchmarks — How your metrics compare to industry standards
  • Compliance Scoring — Gap analysis against frameworks like SOX, HIPAA, and NIST

Report-First Approach

Unlike traditional assessment tools that require lengthy questionnaires, Compass takes a report-first approach. Connect your systems, and you get an AI-generated report immediately — no forms to fill out. If the first draft needs more context or correction, you can use Calibration to review the AI's interpretation before finalizing the baseline.

Availability

Compass is currently available through guided onboarding. We scope connector access, rollout expectations, and commercial terms directly with each organization. There is no public self-serve trial at this stage.